Sep 15, 2025, 08:26
Subcutaneous Prophylaxis for Hemophilia (With or Without Inhibitors) – Novo Nordisk and HFA Webinar
Hemophilia Federation of America (HFA) has shared a post on LinkedIn:
“Join Novo Nordisk and HFA for a special presentation:
‘A New Subcutaneous Prophylaxis Treatment for Hemophilia With and Without Inhibitors.’
Learn about the clinical study, safety and efficacy
Explore an innovative mechanism of action
See the unique prefilled injection pen design
Don’t miss it—mark your calendar and sign up today! ”
You can sign up here.
Discover more on Hemostasis Today.
-
Feb 23, 2026, 17:42Bryan Fry: First Evidence That Bothrops atrox Venom Directly Activates Human Factor VII
-
Feb 23, 2026, 17:34Bastu Odoka: Why Blood Should NOT be Left at the Bedside to ‘Warm’
-
Feb 23, 2026, 17:28Henry Burkitt: Patients Are Challenging How the Medicines Policy System Works in England
-
Feb 23, 2026, 16:50Mutaz Al‑Sabah: Interesting Webinar on FH in Women is Now Available to Watch
-
Feb 23, 2026, 16:36Stéphanie Roullet։ New Method to Explore Primary Haemostasis in Cirrhotic Patients
-
Feb 23, 2026, 16:33Salvatore Massimo Petrina: Top 5 Game-Changers in the AHA and ACC PE Guidelines
-
Feb 23, 2026, 16:21Azin Alizadehasl: Introducing the Second Edition of a New Book on Echocardiography and Cardiac MRI
-
Feb 23, 2026, 16:16Kalyan Roy: When and Why Blood Irradiation Matters in Transfusion Medicine
-
Feb 23, 2026, 15:59Ney Carter Borges: Antithrombotic Therapy in 2025 – A Precision-Based Pharmacologic Update